Literature DB >> 154492

Effect of an inhaled atropinelike agent on normal airway function.

N J Douglas, M F Sudlow, D C Flenley.   

Abstract

Ten normal subjects inhaled 80 microgram ipratropium or placebo. Body plethysmograph studies showed that ipratropium increased specific conductance (0.14-0.21 s-1.cmH2O-1) and increased flow rates during both maximal and partial forced expiratory maneuvers at all volumes from 50 to 10% vital capacity (P less than 0.01). Ipratropium produced no change in quasi-static or dynamic compliance, closing volume, or the slope of phase III of the closing volume trace, but there was an increase in the height of phase IV (P less than 0.01). Specific conductance reflects central airways caliber, whereas flow rates at low lung volumes in the absence of alteration in static recoil pressure may reflect the caliber of more peripheral airways. We conclude that inhibition of vagal tone results in dilatation of large and small airways. Analysis of the flow volume results on the equal pressure point model suggests that the bronchodilatation normally resulting from the inhalation to total lung capacity is not solely due to inhibition of vagal tone.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 154492     DOI: 10.1152/jappl.1979.46.2.256

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  9 in total

Review 1.  Therapeutic aerosols 2--Drugs available by the inhaled route.

Authors:  S W Clarke; S P Newman
Journal:  Thorax       Date:  1984-01       Impact factor: 9.139

2.  Dual effect of prostaglandin E2 on normal airways smooth muscle in vivo.

Authors:  E H Walters; B H Davies
Journal:  Thorax       Date:  1982-12       Impact factor: 9.139

3.  Bronchodilator action of inhaled fenoterol and ipratropium in normal subjects: a teaching exercise for medical students.

Authors:  R G Taylor; J Maclagan; D G Cook
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

Review 4.  Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity.

Authors:  R W Costello; D B Jacoby; A D Fryer
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

5.  The bronchial response to cold air challenge: evidence for different mechanisms in normal and asthmatic subjects.

Authors:  R W Heaton; A F Henderson; B J Gray; J F Costello
Journal:  Thorax       Date:  1983-07       Impact factor: 9.139

6.  Is nocturnal asthma caused by changes in airway cholinergic activity?

Authors:  J R Catterall; G B Rhind; K F Whyte; C M Shapiro; N J Douglas
Journal:  Thorax       Date:  1988-09       Impact factor: 9.139

7.  Site of action of ipratropium bromide and clinical and physiological determinants of response in patients with asthma.

Authors:  M R Partridge; K B Saunders
Journal:  Thorax       Date:  1981-07       Impact factor: 9.139

8.  Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.

Authors:  Richard Hodder; Steven Kesten; Shailendra Menjoge; Klaus Viel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

9.  Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?

Authors:  David Price; Leonard Fromer; Alan Kaplan; Thys van der Molen; Miguel Román-Rodríguez
Journal:  NPJ Prim Care Respir Med       Date:  2014-07-17       Impact factor: 2.871

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.